S9170514
≥96%(HPLC) , 1410880-22-6
Synonym(s):
3-[[4-(Dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[3-methyl-4-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide
| Pack Size | Price | Stock | Quantity |
| 5mg | RMB1688.34 | In Stock |
|
| 25mg | RMB6523.61 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Density | 1.283±0.06 g/cm3(Predicted) |
| storage temp. | 2-8°C |
| solubility | ≥25.4 mg/mL in DMSO; insoluble in H2O; ≥9.24 mg/mL in EtOH with gentle warming and ultrasonic |
| pka | 13.34±0.70(Predicted) |
| form | powder |
| color | white to beige |
Description and Uses
JNK-IN-8 has been used as an inhibitor to address the importance of JNK signaling in withaferin A (WFA)-induced apoptosis of myelodysplastic syndromes (MDS)-L cells.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P305+P351+P338 |
| HS Code | 2933599590 |
